Small Fiber Neuropathy and Advanced Neurological Testing: Why Standard Tests May Miss Nerve Damage

Understanding burning pain, internal vibrations, dysautonomia, POTS, skin biopsies, NeuroQuant MRI, and emerging neurological diagnostic technologies

By Dr. Margaret Christensen, MD

Introduction: When Neurological Symptoms Don't Show Up on Standard Tests

Imagine experiencing burning pain in your feet, unexplained tingling, internal vibrations, dizziness when standing, and a racing heartbeat.

You visit your physician, undergo blood tests, and are referred to a neurologist.

The neurologist orders nerve conduction studies and electromyography (EMG). Perhaps you also have an MRI.

Everything comes back normal.

Yet your symptoms continue.

This is a frustrating experience for many people living with complex neurological conditions, including some individuals recovering from viral illness.

A normal neurological test can be reassuring when it rules out a dangerous or specific disorder. But it does not necessarily mean that every component of the nervous system has been thoroughly evaluated.

Different neurological tests assess different structures and functions.

For example, routine nerve conduction studies primarily evaluate larger peripheral nerve fibers. They are not designed to measure the function of the smallest nerve fibers responsible for many pain, temperature, and autonomic sensations.

This distinction is particularly important when evaluating small fiber neuropathy (SFN).

During our COVID Fallout educational programs, neurologist Dr. Suzanne K. Gazda discussed patients with complex neurological symptoms whose conventional testing did not fully explain their clinical presentations.

Her observations highlight the importance of selecting diagnostic tools based on the type of neurological dysfunction being investigated.

This article explains small fiber neuropathy, why conventional testing may miss it, and how advanced neurological assessments can help clinicians investigate persistent symptoms.

It also explores emerging applications of technologies such as Syn-One skin biopsy testing and NeuroQuant MRI, while distinguishing established diagnostic uses from investigational interpretations.

1. Understanding the Peripheral Nervous System

The nervous system contains different types of nerve fibers, each designed to carry particular forms of information.

Some control movement.

Others transmit sensory information.

Still others contribute to automatic functions such as sweating, blood vessel regulation, and digestion.

A fundamental distinction exists between large nerve fibers and small nerve fibers.

Large Myelinated Nerve Fibers

Large nerve fibers are generally surrounded by a thick myelin sheath.

Myelin acts as electrical insulation and permits rapid signal conduction.

These fibers contribute to:

• Voluntary muscle movement.
• Deep tendon reflexes.
• Vibration perception.
• Joint position awareness.
• Certain aspects of touch sensation.

Routine nerve conduction studies primarily assess the function of large myelinated peripheral fibers.

Needle EMG evaluates electrical activity in muscles and provides information about motor units and selected neuromuscular disorders.

Together, these tests are extremely valuable for diagnosing many neurological conditions.

However, they do not directly evaluate the smallest sensory nerve fibers.

Small Nerve Fibers

Small peripheral nerve fibers include two major groups.

A-delta fibers are thinly myelinated and contribute to pain and temperature perception.

C fibers are largely unmyelinated and participate in pain, temperature, itch, and autonomic signaling.

These fibers transmit information more slowly than large myelinated nerves.

Despite their small size, their physiological importance is enormous.

They are involved in sensations and processes that people experience throughout the day without consciously thinking about them.

Comparing Large and Small Fibers

Feature	Large nerve fibers	Small nerve fibers
Main fiber types	A-alpha and A-beta	A-delta and C
Myelin	Usually thick	Thin or absent
Major functions	Movement, vibration, position sense	Pain, temperature, itch, autonomic signaling
Routine NCS	Usually evaluates these fibers	Does not reliably assess them
Needle EMG	Evaluates motor-unit activity	Does not directly measure small-fiber integrity
Additional assessment	EMG/NCS and neurological examination	Skin biopsy and selected sensory/autonomic tests

This difference explains why someone may experience significant burning pain or temperature abnormalities even when conventional electrodiagnostic studies are normal.

2. What Is Small Fiber Neuropathy?

Small fiber neuropathy is a disorder affecting small peripheral nerve fibers.

Damage or dysfunction may involve sensory fibers, autonomic fibers, or both.

Sensory Small Fiber Neuropathy

Small sensory fibers transmit information related to pain and temperature.

When these fibers are affected, symptoms may include:

• Burning or searing pain.
• Tingling or prickling sensations.
• Electric-shock-like discomfort.
• Unusual sensitivity to touch.
• Changes in temperature perception.
• Painful sensations triggered by clothing or bedsheets.
• Distal numbness or altered sensation.

Some patients describe feeling as though their feet are burning from the inside.

Others report sharp, intermittent electrical sensations.

Allodynia and Hyperalgesia

Two important neurological terms help describe these experiences.

Allodynia occurs when something that ordinarily should not be painful—such as light touch—causes pain.

Hyperalgesia describes an exaggerated pain response to a normally painful stimulus.

These phenomena can occur in several neurological disorders, including neuropathic pain conditions.

Length-Dependent vs. Non-Length-Dependent SFN

Small fiber neuropathy does not always follow the same distribution.

In length-dependent SFN, symptoms often begin in the feet before extending upward.

This pattern may eventually involve the hands.

In non-length-dependent SFN, symptoms can appear in less predictable locations, including the trunk, face, or proximal limbs.

The pattern can provide clues about possible underlying processes and help guide testing.

Does Small Fiber Neuropathy Always Cause Pain?

No.

Some individuals experience reduced sensation rather than severe pain.

Others have prominent autonomic complaints.

The symptom pattern depends partly on which fibers are affected.

3. Small Fiber Neuropathy and Autonomic Dysfunction

The autonomic nervous system helps regulate many processes that occur automatically.

These include heart rate, blood vessel constriction, sweating, temperature regulation, and aspects of gastrointestinal and bladder function.

Small autonomic fibers contribute to several of these processes.

When they are affected, patients may experience symptoms that initially appear unrelated.

Possible Autonomic Symptoms

Symptoms can include:

• Dizziness or lightheadedness when standing.
• Abnormal sweating.
• Heat intolerance.
• Changes in blood vessel regulation.
• Gastrointestinal motility problems.
• Certain bladder symptoms.
• Abnormal heart-rate responses.
• Changes in skin color or temperature.

These findings are not specific to small fiber neuropathy.

Other autonomic, cardiovascular, endocrine, and medical conditions may produce similar symptoms.

Understanding Dysautonomia

Dysautonomia is a broad term describing dysfunction of autonomic nervous-system regulation.

It encompasses multiple disorders rather than representing one diagnosis.

Some forms are associated with peripheral autonomic nerve damage.

Others involve more complex physiological mechanisms.

4. POTS: When Standing Causes an Abnormal Heart-Rate Response

Postural Orthostatic Tachycardia Syndrome, or POTS, is a disorder characterized by chronic orthostatic symptoms together with an excessive increase in heart rate on standing.

In adults, a sustained heart-rate increase of at least 30 beats per minute within ten minutes of standing is one important diagnostic criterion.

For adolescents, the threshold is typically higher.

The diagnosis also requires consideration of blood pressure changes, symptom duration, and other explanations for tachycardia.

What Does POTS Feel Like?

Patients may describe:

• Rapid heartbeat when standing.
• Lightheadedness.
• Palpitations.
• Fatigue.
• Tremulousness.
• Exercise intolerance.
• Cognitive difficulties sometimes described as brain fog.

Symptoms frequently improve after lying down.

Neuropathic POTS

In some patients, impaired peripheral sympathetic nerve function may contribute to abnormal blood vessel constriction.

This can allow excessive blood pooling in the lower extremities when standing.

The resulting physiological response may include an increased heart rate.

Small-fiber abnormalities have been identified in some patients with POTS.

However, not everyone with POTS has small fiber neuropathy.

Hyperadrenergic and Hypovolemic Features

Other patients demonstrate prominent sympathetic activation or evidence of reduced circulating blood volume.

These mechanisms can overlap.

The clinical evaluation should identify the relevant contributors rather than assuming that every case has the same cause.

Why This Matters After COVID

Autonomic symptoms, including POTS-like presentations, have been reported following SARS-CoV-2 infection.

Researchers continue investigating mechanisms that may involve autonomic regulation, immune responses, circulatory changes, or peripheral nerve dysfunction.

These findings make careful evaluation important when patients develop persistent orthostatic symptoms after illness.

5. Internal Vibrations and Other Unusual Neurological Sensations

One symptom discussed by Dr. Gazda and other clinicians is the sensation of internal vibration or buzzing.

Patients sometimes describe feeling as though a cellphone is vibrating inside their body.

Others report intermittent electric sensations or internal tremulousness without visible movement.

These sensations can be difficult to explain.

What Might Cause Internal Vibrations?

Possible contributors include peripheral sensory nerve dysfunction, tremor-related disorders, autonomic changes, medication effects, and other neurological conditions.

Internal vibrations have been reported by some people with long COVID.

However, they are not diagnostic of small fiber neuropathy.

Why Symptom Descriptions Matter

A detailed history can provide valuable information.

The clinician may ask:

• Where is the sensation located?
• Is it constant or intermittent?
• Does it occur when standing or lying down?
• Is it associated with visible shaking?
• Are burning pain or temperature changes present?
• Did symptoms begin after illness, medication exposure, or another event?
• Are there signs of muscle weakness or altered reflexes?

These details help determine which neurological structures may require further investigation.

6. Why EMG and Nerve Conduction Studies May Be Normal

This is one of the most important concepts for patients to understand.

A normal EMG or nerve conduction study does not rule out every type of neuropathy.

What Does EMG Measure?

Needle electromyography measures electrical activity in muscles.

It helps clinicians evaluate disorders involving motor neurons, nerve roots, neuromuscular function, and muscle tissue.

What Do Nerve Conduction Studies Measure?

Nerve conduction studies evaluate electrical responses along accessible peripheral nerves.

They provide important information about larger sensory and motor fibers.

What Don't These Tests Measure?

Routine electrodiagnostic studies do not directly measure the density or function of small unmyelinated C fibers and thinly myelinated A-delta fibers.

Consequently, a person with isolated SFN may have normal routine results.

A normal EMG/NCS is compatible with small fiber neuropathy—but it does not by itself prove that SFN is present.

A diagnosis requires appropriate clinical findings and, when indicated, additional testing.

What Happens Next?

If the symptoms and examination suggest small fiber involvement, a neurologist may consider further assessment, including skin biopsy or selected autonomic tests.

7. Skin Punch Biopsy: Examining Small Nerve Fibers Directly

Skin biopsy is an established method used in evaluating suspected small fiber neuropathy.

It permits microscopic examination of small nerve fibers within the skin.

What Happens During the Procedure?

After local anesthesia, a clinician removes a small sample of skin using a punch biopsy instrument.

The sample is processed by a specialized laboratory.

Staining techniques allow the laboratory to visualize small nerve fibers.

What Is Intraepidermal Nerve Fiber Density?

Intraepidermal nerve fiber density, or IENFD, describes the number of nerve fibers crossing into the epidermis over a defined length of tissue.

Reduced fiber density can support a diagnosis of small fiber neuropathy.

Results are interpreted using appropriate reference ranges and clinical context.

Can a Normal Skin Biopsy Exclude SFN?

Not always.

Sensitivity varies, and sampling location matters.

A person may have small-fiber dysfunction without clearly reduced density at the sampled site.

The results must be interpreted alongside symptoms, examination, and other testing.

What Causes Small Fiber Neuropathy?

Potential causes include diabetes and impaired glucose metabolism, certain autoimmune conditions, nutritional deficiencies, toxic exposures, infections, hereditary disorders, and other diseases.

Sometimes no cause is identified.

Determining whether there is an underlying treatable condition is an important part of the evaluation.

8. Autonomic Testing: Tilt Table, QSART, and Related Assessments

When autonomic dysfunction is suspected, clinicians may use physiological tests designed to evaluate specific autonomic functions.

Tilt-Table Testing

A tilt-table test examines heart-rate and blood-pressure responses during controlled changes in body position.

It may help evaluate orthostatic intolerance and selected autonomic disorders.

It does not directly diagnose small fiber neuropathy.

QSART

The Quantitative Sudomotor Axon Reflex Test assesses a component of sweat-gland nerve function.

Because postganglionic sympathetic fibers involved in sweating include small fibers, abnormal results may provide evidence of autonomic small-fiber dysfunction.

Heart-Rate Variability and Cardiovagal Testing

Certain tests examine autonomic responses during controlled breathing or other maneuvers.

These measurements provide information about aspects of autonomic regulation.

They do not independently establish the underlying cause of dysfunction.

Why a Comprehensive Evaluation Matters

Autonomic symptoms can arise through different mechanisms.

Combining a detailed history, neurological examination, orthostatic vital signs, and appropriate tests can help clinicians distinguish among them.

9. Syn-One Testing: An Emerging Area of Neurological Diagnosis

One of the technologies discussed in Dr. Gazda's educational materials is the Syn-One Test.

This test uses skin biopsies to examine selected nerve-related findings, including phosphorylated alpha-synuclein.

What Is Alpha-Synuclein?

Alpha-synuclein is a protein found in nervous-system tissue.

Abnormal accumulation of certain forms of this protein is associated with neurodegenerative disorders known as synucleinopathies.

These include Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

What Does Syn-One Measure?

Depending on the ordered analysis, the test may assess:

• Phosphorylated alpha-synuclein in cutaneous nerve fibers.
• Epidermal nerve fiber density.
• Certain measures of autonomic nerve innervation.

These findings address different diagnostic questions.

A reduced epidermal nerve fiber density is not the same finding as pathological alpha-synuclein deposition.

Why Is the Test Interesting?

Skin detection of phosphorylated alpha-synuclein has been investigated as a diagnostic biomarker in certain synucleinopathies.

This represents an important area of neurological research.

Can Syn-One Diagnose Long COVID or POTS?

Not on its own.

The possible significance of abnormal alpha-synuclein findings in selected patients with post-viral symptoms or dysautonomia is still being investigated.

A positive result should not be interpreted as proof that COVID caused a degenerative neurological disorder.

Similarly, a negative result does not exclude all forms of autonomic dysfunction or peripheral neuropathy.

Dr. Gazda's Clinical Perspective

Dr. Gazda has emphasized the value of looking beyond conventional electrodiagnostic studies in patients with persistent neurological symptoms.

Her material discusses situations in which skin-based measurements provided additional information after earlier testing was unrevealing.

These cases illustrate the potential value of carefully selected tests.

They do not establish that every person with POTS, internal vibrations, or post-viral symptoms needs Syn-One testing.

10. Standard Brain MRI vs. NeuroQuant Volumetric MRI

Some patients with persistent neurological symptoms undergo conventional MRI.

MRI is a valuable method for assessing brain anatomy.

It can help identify structural lesions, certain inflammatory or demyelinating conditions, tumors, vascular injuries, and other abnormalities.

However, not every neurological disorder produces changes visible on routine imaging.

What Is NeuroQuant?

NeuroQuant is automated software that analyzes MRI data to estimate volumes of selected brain structures.

It can compare these measurements against a reference population.

Examples of regions assessed may include the hippocampus and other anatomical structures.

Why Would a Clinician Use Volumetric Imaging?

Quantitative volume measurements may offer additional information when evaluating certain neurological conditions.

They can support assessment or monitoring in selected clinical circumstances.

Dr. Gazda's Observations

In her COVID Fallout educational presentations, Dr. Gazda describes patients with persistent neurological symptoms whose volumetric MRI findings differed from what clinicians might have expected based on routine imaging reports.

She discusses enlarged or reduced measured brain-region volumes within her broader interpretation of possible neurological involvement.

These observations reflect her clinical experience and interest in integrating advanced imaging with the full patient history.

Does NeuroQuant Diagnose Neuroinflammation?

No. NeuroQuant measures anatomical volumes, not inflammatory cells or inflammatory activity.

An unusually large or small measured structure can have different explanations.

Volume differences can also be affected by anatomical variation, imaging methods, or software-related factors.

A volumetric result cannot independently identify microglial activation, mycotoxin injury, or persistent spike protein.

What About a Normal MRI?

A normal MRI does not exclude small fiber neuropathy, dysautonomia, migraine, or every other neurological condition.

Further testing should be guided by symptoms and examination findings.

11. FDG-PET Imaging and Suspected Autoimmune Encephalitis

Fluorodeoxyglucose positron emission tomography, or FDG-PET, measures patterns of glucose uptake in tissue.

In neurological practice, brain FDG-PET can provide information about regional cerebral metabolism.

When Might It Be Considered?

Specialists may use FDG-PET as part of the assessment of selected neurological disorders.

It can sometimes provide additional information in patients being evaluated for suspected autoimmune encephalitis when other investigations are inconclusive.

What Is Autoimmune Encephalitis?

Autoimmune encephalitis refers to inflammatory brain disorders associated with immune-mediated processes.

Presentations vary, but can include significant changes in cognition, behavior, memory, seizures, movement, or mental status.

Are Antibody Tests Always Positive?

No.

Some patients may have clinically important autoimmune encephalitis without identifying a recognized antibody.

However, negative antibody results and nonspecific symptoms do not automatically establish a diagnosis of seronegative autoimmune encephalitis.

Specialists integrate the clinical course, examination, MRI, EEG, cerebrospinal fluid findings, and other evidence.

Does FDG-PET Confirm Autoimmune Encephalitis?

FDG-PET findings may support a diagnosis in the appropriate setting.

They are not independently definitive.

Abnormal metabolic patterns can occur in multiple neurological conditions.

The test should be selected and interpreted by qualified specialists.

12. What Might Connect Post-Viral Illness and Peripheral Nerve Symptoms?

Researchers have investigated several possible mechanisms linking viral illness with neurological symptoms.

These include immune-mediated processes, inflammatory signaling, vascular changes, and autonomic dysfunction.

Dr. Gazda has discussed multiple hypotheses in her clinical presentations.

Immune-Mediated Nerve Injury

Some immune-mediated disorders can damage peripheral nerves.

Researchers have investigated whether immune processes contribute to selected cases of neuropathy after viral illness.

Autonomic Changes

Persistent autonomic symptoms have been described after SARS-CoV-2 infection.

Some individuals have objective findings consistent with POTS or small-fiber abnormalities.

Others experience similar symptoms without confirmed structural nerve damage.

Vascular and Endothelial Research

Endothelial function, microcirculatory abnormalities, and coagulation-related processes are active areas of research in long COVID.

However, individual findings in experimental studies should not be assumed to explain every case of neuropathy.

Autoantibody Research

Researchers have examined several types of autoantibodies in patients with post-viral symptoms.

Some findings are intriguing, but the clinical significance of individual assays remains uncertain.

A positive experimental antibody result does not necessarily establish causation or direct treatment.

Dr. Gazda's Broader Clinical Model

Dr. Gazda describes neurological symptoms as potentially reflecting interactions among immune, vascular, autonomic, and metabolic systems.

Her approach encourages clinicians to consider mechanisms beyond conventional large-fiber neuropathy.

This perspective can help frame research questions and guide discussion.

The existence of several plausible mechanisms does not mean that all have been demonstrated in an individual patient.

13. How Advanced Neurological Tests Compare

Test	What it measures	Established or principal role	Important limitation
EMG	Electrical activity in muscles	Neuromuscular and motor-unit assessment	Does not directly assess small sensory fibers
Nerve conduction studies	Peripheral nerve electrical responses	Large-fiber neuropathy and related disorders	May be normal in isolated SFN
Skin biopsy for IENFD	Epidermal small nerve fiber density	Supports SFN diagnosis	A normal result does not exclude every form of SFN
QSART	Sudomotor autonomic function	Selected autonomic evaluations	Does not identify every cause of dysautonomia
Tilt-table testing	Heart rate and blood pressure during postural challenge	Selected orthostatic disorders	Does not directly identify nerve pathology
Syn-One	Cutaneous nerve markers, including phosphorylated alpha-synuclein	Evaluation of selected suspected synucleinopathies	Not validated as a universal long-COVID diagnostic test
Conventional MRI	Brain and spinal anatomy	Structural neurological evaluation	May be normal in many neurological conditions
NeuroQuant	Quantitative brain-region volumes	Supplementary structural assessment	Does not directly measure neuroinflammation
FDG-PET	Regional glucose metabolism	Selected neurological evaluations	Abnormal patterns are not disease-specific

14. Clinical Lessons From Dr. Gazda's Presentations

Dr. Gazda's educational material describes several patients with persistent neurological symptoms and complicated diagnostic histories.

The cases emphasize a recurring lesson: an unrevealing initial test should prompt reconsideration of the differential diagnosis when clinically significant symptoms persist.

Clinical Pattern 1: Burning Pain and Normal EMG

A patient experiences burning feet, tingling, and temperature abnormalities.

Routine nerve conduction studies and EMG do not reveal large-fiber abnormalities.

A neurologist considers whether small fiber neuropathy could explain the symptom pattern.

Skin biopsy or selected small-fiber testing may provide additional diagnostic information.

Clinical Pattern 2: Orthostatic Symptoms and Multisystem Complaints

A patient develops rapid heart rate when standing, dizziness, gastrointestinal symptoms, and unusual sweating.

The evaluation considers POTS, other autonomic disorders, medications, fluid status, and additional medical conditions.

Autonomic testing may be appropriate.

Clinical Pattern 3: Cognitive Changes Despite Normal Structural Imaging

A patient reports persistent cognitive difficulties after illness.

The clinician evaluates sleep, mood, medications, endocrine and metabolic conditions, neurological findings, and other possible explanations.

Further imaging or specialized investigations may be considered when the history and examination justify them.

Clinical Pattern 4: Progressive Neurological Symptoms Requiring Specialist Evaluation

A patient develops worsening muscle spasms, gait abnormalities, or significant changes in cognition and behavior.

The appropriate response is not to assume that symptoms represent routine post-viral fatigue.

Such findings may require urgent or specialized neurological assessment for potentially serious conditions.

These educational patterns are adapted from themes in Dr. Gazda's presentations. They are not presented as verified reproductions of individual patients' medical records.

15. Functional Neurological Disorder: Understanding the Diagnosis

Functional Neurological Disorder, or FND, is sometimes misunderstood.

It is a genuine neurological condition involving alterations in nervous-system functioning.

FND is not simply another name for imaginary symptoms or deliberate behavior.

How Is FND Diagnosed?

A qualified clinician diagnoses FND using positive clinical findings and characteristic patterns, not merely because conventional MRI or EMG results are normal.

Can FND and Other Neurological Conditions Coexist?

Yes.

An individual may have FND alongside another neurological or medical condition.

The possibility of coexisting conditions is one reason comprehensive assessment matters.

Why Patients Deserve Clear Explanations

Patients should understand the basis of any neurological diagnosis.

They should be able to ask what findings support it and whether additional evaluation is warranted.

Persistent symptoms deserve respectful assessment regardless of the diagnostic label.

16. Questions to Ask Your Neurologist

If you have unexplained neurological symptoms, consider discussing the following questions with your healthcare professional:

1. Could my symptoms involve small sensory or autonomic nerve fibers?
2. What did my EMG and nerve conduction studies actually evaluate?
3. Would skin biopsy for intraepidermal nerve fiber density be appropriate?
4. Are autonomic tests indicated based on my symptoms?
5. Could I have POTS or another cause of orthostatic intolerance?
6. Should we evaluate metabolic, autoimmune, nutritional, or medication-related causes of neuropathy?
7. Would additional imaging answer a specific clinical question?
8. What would a Syn-One test contribute to my evaluation?
9. If brain volumetric analysis is considered, how would the findings change clinical management?
10. Are any of my symptoms suggestive of a condition requiring urgent neurological assessment?
11. What treatments are supported for my confirmed diagnosis?
12. How will we track symptoms and functional progress?

These questions can help patients participate in their evaluation without assuming that one specialized test will provide every answer.

17. Frequently Asked Questions

Can I have small fiber neuropathy with a normal EMG?

Yes.

Routine EMG and nerve conduction studies may be normal in isolated small fiber neuropathy because they do not directly assess the small fibers involved.

What are the most common symptoms of SFN?

Burning pain, tingling, abnormal temperature sensation, and certain autonomic symptoms are commonly described.

Symptoms vary among patients.

Is skin biopsy painful?

The procedure generally uses local anesthesia and removes a small sample of skin.

Temporary discomfort or minor bleeding may occur.

Does a skin biopsy prove what caused the neuropathy?

No.

It can provide evidence of reduced small-fiber density but does not automatically identify the cause.

What is the difference between SFN and POTS?

SFN describes damage or dysfunction involving small peripheral nerve fibers.

POTS is a syndrome characterized by a specific pattern of orthostatic tachycardia and associated symptoms.

Some patients may have both.

Do all patients with POTS have small fiber neuropathy?

No.

Small-fiber abnormalities are found in a subset of patients.

Can long COVID involve SFN?

Small-fiber abnormalities have been documented in selected patients with long COVID.

The prevalence across all people with long COVID and the mechanisms involved remain subjects of research.

Do internal vibrations mean I have nerve damage?

Not necessarily.

Internal vibrations can have different possible explanations and should be evaluated in context.

Can Syn-One diagnose post-viral neuropathy?

It can evaluate specific cutaneous nerve markers, but it is not a universal diagnostic test for post-viral neuropathy.

Its alpha-synuclein component is principally relevant to suspected synucleinopathies.

Can NeuroQuant show brain inflammation?

NeuroQuant measures anatomical brain volumes.

It cannot directly identify inflammatory activity or determine its cause.

Does a normal MRI mean there is nothing wrong with my nervous system?

No.

Different neurological conditions require different forms of assessment.

A normal MRI may exclude certain structural abnormalities without ruling out peripheral neuropathy or autonomic dysfunction.

Should everyone with brain fog have FDG-PET or NeuroQuant testing?

No.

Specialized imaging should be considered only when it is clinically appropriate and likely to contribute meaningful diagnostic information.

Can small fiber neuropathy improve?

The course depends on the underlying cause and the individual.

Some patients improve when contributing conditions are identified and managed, while others have persistent symptoms.

Treatment may focus on underlying causes, pain management, autonomic symptoms, and maintaining function.

Final Thoughts: The Right Test for the Right Neurological Question

The nervous system is not one uniform structure.

It contains different nerve fibers, signaling pathways, regulatory systems, and anatomical regions.

An examination or diagnostic study designed to evaluate one component may not reveal dysfunction involving another.

This is particularly important in small fiber neuropathy.

A normal routine EMG does not exclude damage to small sensory fibers, just as a normal structural MRI does not exclude every neurological disorder.

Dr. Suzanne Gazda's educational presentations emphasize the importance of considering a broader differential diagnosis when patients experience persistent or unusual neurological symptoms.

Her work explores how skin biopsy, autonomic testing, advanced imaging, and other techniques may contribute information in selected cases.

These tools offer possibilities—but their findings must be interpreted within the limits of what each test measures.

My own approach to complex chronic illness emphasizes careful listening, thoughtful evaluation, and attention to the connections among different physiological systems.

Patients deserve to understand their test results and the reasons particular tests are recommended.

The goal is not to order every advanced neurological test. It is to identify the right questions, select meaningful evaluations, and use the findings to guide responsible medical care.

Continue Exploring

Neurofeedback and qEEG Brain Mapping: Exploring Advanced Therapies for Brain Health

Learn how brain electrical patterns, neurofeedback, NeuroQuant MRI, and neuroplasticity-based approaches are being explored in integrative neurological care.

Read the Neurofeedback Article →

The Functional Medicine Matrix: Understanding the Root Causes of Chronic Illness

Explore a whole-person framework for understanding health and chronic illness.

Read the Functional Medicine Matrix Article →

Advanced & Integrative Therapies

Discover more educational articles about neurological assessment, emerging medical technologies, and integrative approaches.

Explore Advanced Therapies →

COVID Fallout Resources

Explore additional educational resources about persistent symptoms following COVID-19.

Visit the COVID Fallout Resources at MoldDetoxDiet.com →

About the Author

Dr. Margaret Christensen, MD, is a board-certified obstetrician-gynecologist and functional medicine physician whose work includes complex chronic illness, environmental medicine, and patient education.

Her educational programs have featured experts discussing neurological dysfunction, endocrine health, immunology, and integrative medical approaches.

Educational Disclaimer

This article provides general educational information and does not establish a diagnosis or recommend specific testing or treatment for an individual.

Certain diagnostic approaches and clinical interpretations discussed here remain investigational in post-viral illness.

Seek appropriate medical evaluation for persistent neurological symptoms. Sudden weakness, facial drooping, difficulty speaking, acute confusion, new seizures, or other signs of a neurological emergency require immediate medical attention.

Original Source Material and Selected References

Educational sources

• Gazda SK. Emerging Neurological Disorders: A Path to Solutions. 2024 educational presentation.
• Christensen M, Clayton G. Hormonal Havoc: The COVID Fallout and How to Fix It. 2024 e-guide and associated presentations.
• COVID Fallout educational Q&A and related source materials.

Selected research

• Oaklander AL, et al. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurology, 2022.
• Kwan A, et al. Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-CoV-2 Infection. Nature Cardiovascular Research, 2022.
• Wallukat G, et al. Functional Autoantibodies Against G-Protein Coupled Receptors in Patients With Persistent Long-COVID-19 Symptoms. Journal of Translational Autoimmunity, 2021.
• Gibbons C, et al. Research on cutaneous phosphorylated alpha-synuclein detection in synucleinopathies.